View Older Stories View More Recent Stories

Aug 12, 2025 04:04PM Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
Aug 8, 2025 08:05AM Assembly Biosciences prices $175 million equity financing with Gilead
Aug 8, 2025 08:05AM Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
Aug 4, 2025 09:01AM GoPro secures $50 million term loan from Farallon Capital
Aug 4, 2025 09:00AM GoPro Raises $50 Million Secured Term Loan
Jul 18, 2025 08:00AM Visteon appoints Marjorie Sennett to board of directors
Jul 18, 2025 08:00AM Visteon Names Marjorie Sennett to Board of Directors
Jul 18, 2025 08:00AM Visteon Names Marjorie Sennett to Board of Directors
Jul 11, 2025 06:33PM Form SCHEDULE 13G Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Jul 10, 2025 01:33PM JOINT VENTURE OF FETNER PROPERTIES, MCB REAL ESTATE AND FARALLON CAPITAL MANAGEMENT CLOSE ON $209 MILLION ACQUISITION OF 240 WILLOUGHBY STREET IN FORT GREENE, BROOKLYN
Jul 3, 2025 07:09AM Form D/A Farallon Capital F5 Inve
Jul 3, 2025 07:03AM Form D/A Farallon Capital F5 Inve
Jun 30, 2025 11:49AM $252.5M financing secured for a 3.64M SF national industrial portfolio
Jun 20, 2025 02:29PM Form SCHEDULE 13G 23andMe Holding Co. Filed by: Farallon Capital Partners, L.P.
Jun 16, 2025 04:20AM At Home Group Enters Agreement to Facilitate Ownership Transition and Position Business for Long-Term Success
Jun 13, 2025 05:25PM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Jun 2, 2025 04:00AM Farallon Capital Management Releases Investor Presentation Outlining Value Creation Opportunities at T&D Holdings and the Need for Additional Independent Outside Directors
May 20, 2025 05:59PM Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
May 15, 2025 09:24AM Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
May 15, 2025 09:23AM Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
May 15, 2025 09:22AM Form SCHEDULE 13G Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
May 15, 2025 09:05AM Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
May 15, 2025 09:04AM Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
May 15, 2025 09:02AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 15, 2025 09:01AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
May 15, 2025 09:01AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
May 15, 2025 08:58AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 13, 2025 03:46PM Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
May 8, 2025 04:10PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
May 7, 2025 04:25PM Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
May 7, 2025 04:21PM Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Mar 12, 2025 09:00AM Pentera Secures $60M to Lead Security Validation Market Consolidation and Drive Next Phase of Growth
Mar 7, 2025 09:47AM Form D/A FARALLON CAPITAL OFFSHOR
Mar 7, 2025 09:42AM Form D/A Farallon Capital Partner
Mar 7, 2025 09:37AM Form D/A Farallon Capital (AM)
Mar 7, 2025 09:32AM Form D/A Farallon Capital Institu
Mar 5, 2025 05:02PM Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Feb 18, 2025 03:37PM Form SCHEDULE 13G NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
Feb 18, 2025 03:37PM Form SCHEDULE 13G Aramark Filed by: Farallon Capital Partners, L.P.
Feb 14, 2025 09:01AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
Feb 14, 2025 09:01AM Form 13F-NT Farallon Capital Europe For: Dec 31
Feb 14, 2025 09:00AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 14, 2025 08:59AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Feb 14, 2025 08:59AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 12, 2025 12:04AM Farallon Capital Builds Over 3% Position In Japan's Astellas- FT
Feb 11, 2025 05:14PM Form SCHEDULE 13G/A Savara Inc Filed by: Farallon Capital Partners, L.P.
Feb 11, 2025 12:11PM Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: Farallon Capital Partners, L.P.
Feb 10, 2025 08:21PM Bain Capital says it may withdraw tender offer proposal for Fuji Soft
Feb 10, 2025 02:33PM Form SCHEDULE 13G/A AleAnna, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 10, 2025 12:47PM Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
View More Recent Stories View Older Stories